The oligometastatic state in breast cancer: hypothesis or reality.

The term 'oligometastasis' was initially used to describe a restricted locoregional tumour load, but the term has now become synonymous with isolated distant metastases. The existence of an oligometastatic state is still not widely recognised in the management of breast cancer patients. However, there are a number of patients who do develop isolated metastases and in whom long term survival can be achieved following appropriately targeted treatment. This review article discusses the possible biological mechanisms behind the development of an oligometastatic state and the findings from different trials which describe results following radical therapy for isolated metastatic disease. Although no large scale trials in this area have yet been undertaken, there is evidence to support the existence of an oligometastatic state in patients with breast cancer and we discuss the appropriate management for this clinical scenario.

[1]  Y. Uchida,et al.  Surgical treatment of hepatic metastases from breast cancer , 2004, Breast Cancer Research and Treatment.

[2]  R. Gelber,et al.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.

[3]  M. Mehta,et al.  A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. , 1996, International journal of radiation oncology, biology, physics.

[4]  R. Demicheli,et al.  Tumour dormancy: findings and hypotheses from clinical research on breast cancer. , 2001, Seminars in cancer biology.

[5]  S. Noguchi,et al.  Results of surgical treatment for sternal metastasis of breast cancer , 1988, Cancer.

[6]  E. Noordijk,et al.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. , 1994, International journal of radiation oncology, biology, physics.

[7]  S. Rosenberg.  Surgical treatment of metastatic cancer , 1987 .

[8]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[9]  C. Mountain,et al.  The contribution of surgery to the management of carcinomatous pulmonary metastases , 1978, Cancer.

[10]  L D Lunsford,et al.  A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. , 1994, International journal of radiation oncology, biology, physics.

[11]  R. Liščák,et al.  Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  A. Rongione,et al.  Pulmonary resection for metastatic breast cancer. , 1992, Archives of surgery.

[13]  P. Müller,et al.  Surgical Treatment of Bone Metastases in Patients With Breast Cancer , 2002, Clinical orthopaedics and related research.

[14]  Y. Marcou,et al.  What is the optimal therapy of brain metastases? , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[15]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[16]  G. Hortobagyi,et al.  The natural history of breast cancer patients with brain metastases , 1979, Cancer.

[17]  M. Kissin,et al.  Hepatic resection for breast cancer metastases. , 2005, Annals of the Royal College of Surgeons of England.

[18]  Ronald Brand,et al.  Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.

[19]  E. Shpall,et al.  Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  G. Hortobagyi,et al.  Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[22]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[23]  R. Rubens,et al.  Clinical course and prognostic factors following bone recurrence from breast cancer. , 1998, British Journal of Cancer.

[24]  Yoshiaki Tsukada,et al.  Central nervous system metastasis from breast carcinoma autopsy study , 1983, Cancer.

[25]  M Buyse,et al.  Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. , 1997, The Journal of thoracic and cardiovascular surgery.

[26]  M. Walker,et al.  The regional treatment of liver metastases from breast cancer , 1994, Journal of surgical oncology.

[27]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[28]  Bingham Ja.  Letter: Lower oesophageal sphincter. , 1974 .

[29]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[30]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[31]  H. Maruno,et al.  Bone scintigraphy in patients with breast cancer: malignant involvement of the sternum. , 1994, Radiation medicine.

[32]  S. Hellman,et al.  Karnofsky Memorial Lecture. Natural history of small breast cancers. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  J. Roth,et al.  Long-term survival after resection of pulmonary metastases from carcinoma of the breast. , 1992, The Annals of thoracic surgery.

[34]  D. Elias,et al.  Hepatectomy for liver metastases from breast cancer. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  W. Meyers,et al.  Liver metastases from breast cancer: long-term survival after curative resection. , 2000, Surgery.

[36]  W. Halsted.  I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. , 1907, Annals of surgery.

[37]  P. Pairolero,et al.  Pulmonary resection for metastatic breast cancer. , 1994, The Annals of thoracic surgery.

[38]  G. Friedel,et al.  The Significance of Prognostic Factors for the Resection of Pulmonary Metastases of Breast Cancer , 1994, The Thoracic and cardiovascular surgeon.

[39]  R. Salmon,et al.  Résections hépatiques pour métastases de cancer du sein : résultats et facteurs pronostiques (65 cas) , 2001 .

[40]  P. Levendag,et al.  Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. , 1999, International journal of radiation oncology, biology, physics.

[41]  R. Coleman,et al.  Bone secondaries in breast cancer: the solitary metastasis. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  A. Weimann,et al.  Liver metastases of breast cancer: results of liver resection. , 1998, Anticancer research.

[43]  C. Redmond,et al.  The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings , 1980, Cancer.

[44]  A. Hart,et al.  Brain metastases in breast cancer; natural history, prognostic factors and outcome , 1993, Journal of Neuro-Oncology.

[45]  H. Defesche.  Cerebral metastases from pulmonary and mammary carcinomas , 1982, Clinical Neurology and Neurosurgery.

[46]  A. Lees,et al.  Brain metastases in breast cancer patients receiving adjuvant chemotherapy , 1982, Cancer.

[47]  G. Barnett,et al.  Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery. , 1997, Radiation oncology investigations.

[48]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[49]  I. Bross,et al.  An autopsy study of metastatic sites of breast cancer. , 1973, Cancer research.

[50]  E R Laws,et al.  Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival. , 1987, International journal of radiation oncology, biology, physics.

[51]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[52]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Scher,et al.  Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. , 1987, The American journal of medicine.